Fisher to sell Cholestech LDX System in US:
This article was originally published in Clinica
Executive Summary
Fisher HealthCare is to distribute Cholestech's LDX System in the US under a multi-year, non-exclusive agreement. Haywood, California-based Cholestech's product, which aids in the detection of cardiovascular disease, is a telephone-sized device that carries out multiple, simultaneous tests from a drop of blood, providing results in under five minutes. The company claims results are as accurate as similar tests conducted in clinical and hospital labs. Fisher HealthCare, a division of Fisher Scientific, plans to distribute the product to over 75,000 acute care and physician office laboratories.